Epigenetic and genetic alterations of p33ING1b in ovarian cancer. [electronic resource]
Producer: 20050503Description: 855-63 p. digitalISSN:- 0143-3334
- Adenocarcinoma, Clear Cell -- genetics
- Antimetabolites, Antineoplastic -- pharmacology
- Azacitidine -- analogs & derivatives
- Carcinoma, Endometrioid -- genetics
- Case-Control Studies
- Cell Cycle Proteins
- CpG Islands
- Cystadenocarcinoma, Mucinous -- genetics
- Cystadenocarcinoma, Serous -- genetics
- DNA Methylation
- DNA-Binding Proteins
- Decitabine
- Female
- Gene Expression Regulation, Neoplastic
- Genes, Tumor Suppressor
- Humans
- Immunoenzyme Techniques
- Inhibitor of Growth Protein 1
- Intracellular Signaling Peptides and Proteins
- Loss of Heterozygosity
- Mutation -- genetics
- Nuclear Proteins
- Ovarian Neoplasms -- genetics
- Ovary -- metabolism
- Promoter Regions, Genetic -- genetics
- Proteins -- genetics
- RNA, Messenger -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Tumor Cells, Cultured
- Tumor Suppressor Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.